Himachal Pradesh, India

Ruchi Acharya


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2003-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ruchi Acharya: Innovator in Neolignan Research

Introduction

Ruchi Acharya is a prominent inventor based in Himachal Pradesh, India. She has made significant contributions to the field of chemistry, particularly in the development of novel neolignans. With a total of 2 patents, her work focuses on the transformation of natural compounds into pharmacologically active substances.

Latest Patents

Ruchi Acharya's latest patents include innovative processes for the preparation of high-purity compounds from β-asarone-rich Acorus calamus oil. One of her notable inventions is the "DDQ mediated one step dimerization of β-asarone or β-asarone rich Acorus calamus oil in the formation of novel neolignan." This invention relates to the creation of a neolignan known as NEOLASA-I, which involves a complex process of hydrogenation and dimerization using DDQ in the presence of organic acids. Another significant patent is the "Process for the preparation of pharmacologically active α-asarone from toxic β-asarone rich Acorus calamus oil." This process also utilizes DDQ treatment to yield high-purity α-asarone and other valuable compounds.

Career Highlights

Ruchi Acharya is affiliated with the Council of Scientific and Industrial Research, where she conducts her research and development activities. Her work has garnered attention for its potential applications in pharmaceuticals and natural product chemistry.

Collaborations

Ruchi has collaborated with esteemed colleagues such as Arun Kumar Sinha and Bhupendra Prasad Joshi, contributing to a dynamic research environment that fosters innovation.

Conclusion

Ruchi Acharya's contributions to the field of chemistry, particularly in the area of neolignan research, highlight her role as a leading inventor. Her innovative patents reflect her commitment to advancing scientific knowledge and developing new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…